Pulmonary veno-occlusive disease: a probably underdiagnosed cause of pulmonary hypertension in systemic sclerosis.
Duarte AC, Cordeiro A, Loureiro MJ, Ferreira F.
Clin Rheumatol. 2020 May;39(5):1687-1691. doi: 10.1007/s10067-020-04953-4. Epub 2020 Jan 22.
Pulmonary function tests as outcomes for systemic sclerosis interstitial lung disease.
Caron M, Hoa S, Hudson M, Schwartzman K, Steele R.
Eur Respir Rev. 2018 May 15;27(148):170102. doi: 10.1183/16000617.0102-2017. Print 2018 Jun 30.
Pulmonary sclerosis.
JERVELL O.
Acta Med Scand. 1950;138(6):430-6. doi: 10.1111/j.0954-6820.1950.tb10141.x.
Long-Term Safety and Efficacy of Tocilizumab in Early Systemic Sclerosis-Interstitial Lung Disease: Open-Label Extension of a Phase 3 Randomized Controlled Trial.
Khanna D, Lin CJF, Furst DE, Wagner B, Zucchetto M, Raghu G, Martinez FJ, Goldin J, Siegel J, Denton CP.
Am J Respir Crit Care Med. 2022 Mar 15;205(6):674-684. doi: 10.1164/rccm.202103-0714OC.
Acute mediastinitis, mediastinal granuloma, and chronic fibrosing mediastinitis: A review.
Lin J, Jimenez CA.
Semin Diagn Pathol. 2022 Mar;39(2):113-119. doi: 10.1053/j.semdp.2021.06.008. Epub 2021 Jun 15.
How Is Pulmonary Function Assessed in Patients With Juvenile Systemic Sclerosis? Do We Have a Good Clinical Standard?
Foeldvari I, Hinrichs B, Torok K, Rosser F, Helmus N.
J Rheumatol. 2023 Sep;50(9):1194-1195. doi: 10.3899/jrheum.2022-0993. Epub 2023 Apr 15.
[Pulmonary sclerosis].
JULICH H.
Z Arztl Fortbild (Jena). 1954 Jul 1;48(13):437-9.
Advances in the identification and management of progressive pulmonary fibrosis: perspective from Chinese experts.
Huang H, Wang Q, Xu Z.
Ther Adv Respir Dis. 2024 Jan-Dec;18:17534666241288417. doi: 10.1177/17534666241288417.
Survival in progressive systemic sclerosis with pulmonary involvement: a single-center experience in Istanbul, Turkey.
Zuhur F, Zuhur SS, Zuhur C, Musellim B, Ongen G.
Rheumatol Int. 2012 Jun;32(6):1655-61. doi: 10.1007/s00296-011-1842-x. Epub 2011 Mar 5.
Single Test-Based Diagnosis and Subtyping of Pulmonary Hypertension Caused by Fibrosing Mediastinitis Using Plasma Metabolic Analysis.
Zhao Y, Ding C, Su H, Wang A, Tang A, Zhao H, Ma Y, Zhang M, Liu W, Wang R, Zhang Z, Yang S, Liang D, Huang Y, Qian K, Huang L, Fu Q, Cao Y.
Adv Sci (Weinh). 2025 May;12(17):e2416454. doi: 10.1002/advs.202416454. Epub 2025 Mar 6.
